These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 37338615)
1. Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson's disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial. Laurencin C; Timestit N; Marques A; Duchez DD; Giordana C; Meoni S; Huddlestone M; Danaila T; Anheim M; Klinger H; Vidal T; Fatisson M; Caire C; Nourredine M; Boulinguez P; Dhelens C; Ballanger B; Prange S; Bin S; Thobois S J Neurol; 2023 Oct; 270(10):4851-4859. PubMed ID: 37338615 [TBL] [Abstract][Full Text] [Related]
2. Validation of the Italian version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS) in an Italian Parkinson's disease cohort. Maggi G; Vitale C; Giacobbe C; Barone A; Mastromarino C; Iannotta F; Amboni M; Weintraub D; Santangelo G Neurol Sci; 2024 Jul; 45(7):3153-3161. PubMed ID: 38231374 [TBL] [Abstract][Full Text] [Related]
3. French validation of the questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS). Marques A; Vidal T; Pereira B; Benchetrit E; Socha J; Pineau F; Elbaz A; Artaud F; Mangone G; You H; Cormier F; Galitstky M; Pomies E; Rascol O; Derkinderen P; Weintraub D; Corvol JC; Durif F; Parkinsonism Relat Disord; 2019 Jun; 63():117-123. PubMed ID: 30862454 [TBL] [Abstract][Full Text] [Related]
4. Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study. Papay K; Xie SX; Stern M; Hurtig H; Siderowf A; Duda JE; Minger J; Weintraub D Neurology; 2014 Aug; 83(9):826-33. PubMed ID: 25037206 [TBL] [Abstract][Full Text] [Related]
5. Impulse control disorders in Parkinson's: Sleep disorders and nondopaminergic associations. Carbunaru S; Eisinger RS; Ramirez-Zamora A; Bassan D; Cervantes-Arriaga A; Rodriguez-Violante M; Martinez-Ramirez D Brain Behav; 2018 Mar; 8(3):e00904. PubMed ID: 29541533 [TBL] [Abstract][Full Text] [Related]
8. Non-motor symptom burden in patients with Parkinson's disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort. Jesús S; Labrador-Espinosa MA; Adarmes AD; Méndel-Del Barrio C; Martínez-Castrillo JC; Alonso-Cánovas A; Sánchez Alonso P; Novo-Ponte S; Alonso-Losada MG; López Ariztegui N; Segundo Rodríguez JC; Morales MI; Gastón I; Lacruz Bescos F; Clavero Ibarra P; Kulisevsky J; Pagonabarraga J; Pascual-Sedano B; Martínez-Martín P; Santos-García D; Mir P; Sci Rep; 2020 Oct; 10(1):16893. PubMed ID: 33037247 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of Impulsive-Compulsive Symptoms in Elderly Parkinson's Disease Patients: A Case-Control Study. Lo Monaco MR; Petracca M; Weintraub D; Fusco D; Liperoti R; Zuccalà G; La Carpia D; Vetrano DL; Genovese D; Pisciotta MS; Brandi V; Padua L; Imbimbo I; Ricciardi D; Bernabei R; Silveri MC; Laudisio A; Bentivoglio AR J Clin Psychiatry; 2018; 79(3):. PubMed ID: 29702754 [TBL] [Abstract][Full Text] [Related]
10. Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation. Simoni S; Paoletti FP; Eusebi P; Cappelletti G; Filidei M; Brahimi E; Nigro P; Santangelo V; Parnetti L; Calabresi P; Tambasco N J Parkinsons Dis; 2020; 10(3):927-934. PubMed ID: 32280105 [TBL] [Abstract][Full Text] [Related]
11. Screening for impulse control disorders in Parkinson's disease and dopamine agonist use: a study of pharmacokinetic and psychological risk factors. Contin M; Lopane G; Marini L; Mohamed S; Sambati L; De Massis P; Guarino M; Sermi S; Persichella C; Cortelli P; Calandra-Buonaura G Neurol Sci; 2023 Feb; 44(2):565-572. PubMed ID: 36350455 [TBL] [Abstract][Full Text] [Related]
12. Impulse control disorders are associated with lower ventral striatum dopamine D3 receptor availability in Parkinson's disease: A [ Pagano G; Molloy S; Bain PG; Rabiner EA; Ray Chaudhuri K; Brooks DJ; Pavese N Parkinsonism Relat Disord; 2021 Sep; 90():52-56. PubMed ID: 34385007 [TBL] [Abstract][Full Text] [Related]
13. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease (QUIP) and the QUIP-rating scale in a German speaking sample. Probst CC; Winter LM; Möller B; Weber H; Weintraub D; Witt K; Deuschl G; Katzenschlager R; van Eimeren T J Neurol; 2014 May; 261(5):936-42. PubMed ID: 24609972 [TBL] [Abstract][Full Text] [Related]
14. Validation of the Korean Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease Rating Scale. Choi JH; Lee JY; Cho JW; Ko SB; Ahn TB; Kim SJ; Cheon SM; Kim JS; Kim YJ; Ma HI; Baik JS; Lee PH; Chung SJ; Kim JM; Song IU; Kim HJ; Sung YH; Kwon DY; Lee JH; Kim JY; Kim JS; Yun JY; Kim HJ; Hong JY; Kim MJ; Youn J; Kim JS; Oh ES; Yang HJ; Yoon WT; You S; Kwon KY; Park HE; Lee SY; Kim Y; Kim HT; Park MY J Clin Neurol; 2020 Apr; 16(2):245-253. PubMed ID: 32319241 [TBL] [Abstract][Full Text] [Related]
15. Impulse Control Disorders in the Polish Population of Patients with Parkinson's Disease. Toś M; Grażyńska A; Antoniuk S; Siuda J Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629758 [No Abstract] [Full Text] [Related]
16. Impulsive compulsive behaviors in Japanese Parkinson's disease patients and utility of the Japanese version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's disease. Tanaka K; Wada-Isoe K; Nakashita S; Yamamoto M; Nakashima K J Neurol Sci; 2013 Aug; 331(1-2):76-80. PubMed ID: 23735774 [TBL] [Abstract][Full Text] [Related]